Publications by authors named "Jon Laye"

Claim this Profile
T
Tumour-Infiltrating Lymphocytes, Tumour Cell Density, and Response to Neoadjuvant Short-Course Radiotherapy in Rectal Cancer: A Translational Sub-Study from the MRC CR07 Clinical Trial.
Jonathan P Callaghan, Ross Jarrett, Alice C Westwood, Jon Laye, Philip Quirke

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-learning enabled combined measurement of tumour cell density and tumour infiltrating lymphocyte density as a prognostic biomarker in colorectal cancer.
Alice C Westwood, Benjamin I Wilson, Jon Laye, Heike I Grabsch, Wolfram Mueller

BJC Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Inflammation, the Peripheral Blood Transcriptome, and Primary Melanoma.
Juliette Randerson-Moor, John Davies, Mark Harland, Jérémie Nsengimana, Theophile Bigirumurame, Jon Laye

J Invest Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial.
Drolaiz H W Liu, Young-Woo Kim, Nina Sefcovicova, Jon P Laye, Lindsay C Hewitt

Br J Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicity.
John Davies, Sathya Muralidhar, Juliette Randerson-Moor, Mark Harland, Sally O'Shea, Jon Laye

Pigment Cell Melanoma Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material.
Anastasia Filia, Alastair Droop, Mark Harland, Helene Thygesen, Juliette Randerson-Moor, Jon Laye

Sci Rep· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas.
Jérémie Nsengimana, Jon Laye, Anastasia Filia, Sally O'Shea, Sathya Muralidhar

J Clin Invest· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.
Jérémie Nsengimana, Jon Laye, Anastasia Filia, Christy Walker, Rosalyn Jewell

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity.
Matthew A Care, Mario Cocco, Jon P Laye, Nicholas Barnes, Yuanxue Huang

Nucleic Acids Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy.
Rachel Abbotts, Rosalyn Jewell, Jérémie Nsengimana, David J Maloney, Anton Simeonov, Jon Laye

Oncotarget· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic features of V600E and V600K melanoma--letter.
Rosalyn Jewell, Philip Chambers, Mark Harland, Jon Laye, Caroline Conway

Clin Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis